相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revving the CAR-Combination strategies to enhance CAR T cell effectiveness
Rajat Bansal et al.
BLOOD REVIEWS (2021)
Counteracting CAR T cell dysfunction
Mansour Poorebrahim et al.
ONCOGENE (2021)
Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming
Yao Wang et al.
NATURE COMMUNICATIONS (2021)
Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer
Tyler R. McCaw et al.
CANCER MEDICINE (2021)
Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis
Haiyong Wang et al.
CANCERS (2021)
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
Marsha Pellegrino et al.
CELLS (2021)
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment
Norihiro Watanabe et al.
MOLECULAR THERAPY (2021)
Immunotherapy for sarcomas: new frontiers and unveiled opportunities
Harsimrat Kaur Birdi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Cell-programmed nutrient partitioning in the tumour microenvironment
Bradley Reinfeld et al.
NATURE (2021)
NAD+ metabolism, stemness, the immune response, and cancer
Lola E. Navas et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Epigenetic programming-The important first 1000 days
Agnes Linner et al.
ACTA PAEDIATRICA (2020)
Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming
Dominic G. Roy et al.
CELL METABOLISM (2020)
The interplay between HIF-1α and noncoding RNAs in cancer
Xiafeng Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity
Dalton Hermans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Histone Lactylation: A New Role for Glucose Metabolism
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen
Gwennaelle C. Monnot et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma
Virginie Vignard et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Jean-Christophe Beltra et al.
IMMUNITY (2020)
Differentiation of Pathogenic Th17 Cells Is Negatively Regulated by Let-7 MicroRNAs in a Mouse Model of Multiple Sclerosis
Constance C. Angelou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells
Elham Masoumi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Gene modification strategies for next-generation CAR T cells against solid cancers
Yonggui Tian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells
Junmei Wang et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward
Leila Jafarzadeh et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer
Can Lu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Next-Generation Manufacturing Protocols Enriching TSCMCAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
Silvia Arcangeli et al.
FRONTIERS IN IMMUNOLOGY (2020)
Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
Yuna Jo et al.
CANCERS (2020)
Rewriting History: Epigenetic Reprogramming of CD8+T Cell Differentiation to Enhance Immunotherapy
Caitlin C. Zebley et al.
TRENDS IN IMMUNOLOGY (2020)
miR-708-5p targets oncogenic prostaglandin E2 production to suppress a pro-tumorigenic phenotype in lung cancer cells
Nicholas J. Monteleone et al.
Oncotarget (2020)
Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells
Liangshun You et al.
FRONTIERS IN IMMUNOLOGY (2020)
Lingering effects of chemotherapy on mature T cells impair proliferation
Rajat K. Das et al.
BLOOD ADVANCES (2020)
The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome
Iosifina P. Foskolou et al.
BLOOD ADVANCES (2020)
Persistent STAT5 activation reprograms the epigenetic landscape in CD4+ T cells to drive polyfunctionality and antitumor immunity
Zhi-Chun Ding et al.
SCIENCE IMMUNOLOGY (2020)
Exosomes: key players in cancer and potential therapeutic strategy
Jie Dai et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation
Teresa Preglej et al.
JCI INSIGHT (2020)
Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia
Bei Jia et al.
CANCER RESEARCH (2019)
Enhancing tumor T cell infiltration to enable cancer immunotherapy
Jin Zhang et al.
IMMUNOTHERAPY (2019)
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
Sareetha Kailayangiri et al.
MOLECULAR THERAPY (2019)
NR4A transcription factors limit CAR T cell function in solid tumours
Joyce Chen et al.
NATURE (2019)
Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas
Philipp Lingohr et al.
EPIGENOMICS (2019)
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
Lanlan Gao et al.
EBIOMEDICINE (2019)
The metabolic spectrum of memory T cells
David O'Sullivan
IMMUNOLOGY AND CELL BIOLOGY (2019)
Acetate Promotes T Cell Effector Function during Glucose Restriction
Jing Qiu et al.
CELL REPORTS (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
Advances in cancer immunotherapy 2019-latest trends
Stephan Kruger et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Co-inhibition of BET proteins and PD-L1 as a potential therapy for OSCC through synergistic inhibition of FOXM1 and PD-L1 expressions
Wei Wang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion
Hyungseok Seo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma
Sujun Li et al.
ONCOTARGETS AND THERAPY (2019)
miR-15/16 Restrain Memory T Cell Differentiation, Cell Cycle, and Survival
John D. Gagnon et al.
CELL REPORTS (2019)
miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer
Qiong Lou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Metabolic regulation of gene expression by histone lactylation
Di Zhang et al.
NATURE (2019)
Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
Fan Zou et al.
NATURE COMMUNICATIONS (2019)
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
Tushar D. Bhagat et al.
ELIFE (2019)
VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers
Chang Gon Kim et al.
SCIENCE IMMUNOLOGY (2019)
Expressional activation and functional roles of human endogenous retroviruses in cancers
Mengwen Zhang et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
c-Jun overexpression in CAR T cells induces exhaustion resistance
Rachel C. Lynn et al.
NATURE (2019)
Naive T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers
Rajat K. Das et al.
CANCER DISCOVERY (2019)
TGF-β and microRNA Interplay in Genitourinary Cancers
Joanna Boguslawska et al.
CELLS (2019)
Elevated expression of miR-146a correlates with high levels of immune cell exhaustion markers and suppresses cellular immune function in chronic HIV-1-infected patients
Ting Yu et al.
SCIENTIFIC REPORTS (2019)
The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signaling
Jian Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors
Michael Daskalakis et al.
CELL CYCLE (2018)
Metabolic regulation of chromatin modifications and gene expression
Juan Manuel Schvartzman et al.
JOURNAL OF CELL BIOLOGY (2018)
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Shaofei Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
Qian Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition
Yue Yu et al.
MOLECULAR CANCER (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Silencing stemness in T cell differentiation
Amanda N. Henning et al.
SCIENCE (2018)
The epigenetic control of stemness in CD8+ T cell fate commitment
Luigia Pace et al.
SCIENCE (2018)
Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells
Naohiro Seo et al.
NATURE COMMUNICATIONS (2018)
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
Na Luo et al.
NATURE COMMUNICATIONS (2018)
The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations
Roddy S. O'Connor et al.
SCIENTIFIC REPORTS (2018)
Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions
Ashley V. Menk et al.
CELL REPORTS (2018)
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi et al.
CANCER IMMUNOLOGY RESEARCH (2018)
miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism
Tengfei Zhang et al.
JOURNAL OF IMMUNOLOGY (2018)
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta et al.
NATURE (2018)
miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma
Chengshuo Zhang et al.
BMC CANCER (2018)
Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
Jieru Zhou et al.
CANCER IMMUNOLOGY RESEARCH (2018)
High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells
Jing Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Unraveling the Complex Interplay Between T Cell Metabolism and Function
Ramon I. Klein Geltink et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Epigenetic control of CD8+ T cell differentiation
Amanda N. Henning et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Epigenetic Networks Regulate the Transcriptional Program in Memory and Terminally Differentiated CD8+ T Cells
Ramon M. Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2017)
Non-coding RNAs as regulators in epigenetics
Jian-Wei Wei et al.
ONCOLOGY REPORTS (2017)
SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells
Tom L. Stephen et al.
IMMUNITY (2017)
Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells
Jihao Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis
Hossam A. Abdelsamed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer
Jianjie Zhu et al.
MOLECULAR CANCER (2017)
Effector CD8 T cells dedifferentiate into long-lived memory cells
Ben Youngblood et al.
NATURE (2017)
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip et al.
NATURE (2017)
Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells
Giuliana P. Mognol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
Meredith L. Stone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
New Dancing Couple: PD-L1 and MicroRNA
A. Grenda et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity
Shan He et al.
NATURE COMMUNICATIONS (2017)
miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb
Zeyu Chen et al.
CELL REPORTS (2017)
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
Daniel Zingg et al.
CELL REPORTS (2017)
Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Marc Hennequart et al.
CANCER IMMUNOLOGY RESEARCH (2017)
TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells
Stefano Regis et al.
FRONTIERS IN IMMUNOLOGY (2017)
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
Hamid R. Mirzaei et al.
FRONTIERS IN IMMUNOLOGY (2017)
NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
Kevin Brennan et al.
SCIENTIFIC REPORTS (2017)
De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Hazem E. Ghoneim et al.
CELL (2017)
Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA sequencing
Boyko Kakaradov et al.
NATURE IMMUNOLOGY (2017)
Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape
Joseph G. Crompton et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
Jun Wei et al.
NEURO-ONCOLOGY (2016)
MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma
Qianting He et al.
BMC CANCER (2016)
DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer
Krista P. Terracina et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
The crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A
Ranran Kong et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2016)
MicroRNA-150 negatively regulates the function of CD4+ T cells through AKT3/Bim signaling pathway
Wei Sang et al.
CELLULAR IMMUNOLOGY (2016)
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
Andrea Schietinger et al.
IMMUNITY (2016)
CD8+ T Cells Utilize Highly Dynamic Enhancer Repertoires and Regulatory Circuitry in Response to Infections
Bing He et al.
IMMUNITY (2016)
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E. Scharping et al.
IMMUNITY (2016)
Dynamic Changes in Chromatin Accessibility Occur in CD8+ T Cells Responding to Viral Infection
James P. Scott-Browne et al.
IMMUNITY (2016)
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
Yuki Kagoya et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses
Andre Kunert et al.
JOURNAL OF IMMUNOLOGY (2016)
MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease
Laura L. Dickey et al.
JOURNAL OF NEUROINFLAMMATION (2016)
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate
Petros A. Tyrakis et al.
NATURE (2016)
De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation
Brian H. Ladle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism
Min Peng et al.
SCIENCE (2016)
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Kristen E. Pauken et al.
SCIENCE (2016)
miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion
Qing Li et al.
ONCOTARGET (2016)
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
Nathalie Bonnin et al.
ONCOTARGET (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
Protein SUMOylation Is Required for Regulatory T Cell Expansion and Function
Xiao Ding et al.
CELL REPORTS (2016)
modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient
Imran Siddiqui et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Therapeutics in Cancer - An Emerging Concept
Maitri Y. Shah et al.
EBIOMEDICINE (2016)
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
Soranobu Ninomiya et al.
BLOOD (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma
Janani Krishnamurthy et al.
CLINICAL CANCER RESEARCH (2015)
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8+ T Cells
Gustavo J. Martinez et al.
IMMUNITY (2015)
DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine
Min Sun Shin et al.
JOURNAL OF IMMUNOLOGY (2015)
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng et al.
NATURE (2015)
Three-dimensional genome architecture: players and mechanisms
Ana Pombo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
Yun Bai et al.
CELL DISCOVERY (2015)
Distinct Epigenetic Signatures Delineate Transcriptional Programs during Virus-Specific CD8+ T Cell Differentiation
Brendan E. Russ et al.
IMMUNITY (2014)
IL-15 regulates memory CD8+ T cell IL-15-glycan synthesis and affects trafficking
Jeffrey C. Nolz et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Dual Effect of CTCF Loss on Neuroprogenitor Differentiation and Survival
L. Ashley Watson et al.
JOURNAL OF NEUROSCIENCE (2014)
miR141-CXCL1-CXCR2 Signaling-Induced Treg Recruitment Regulates Metastases and Survival of Non-Small Cell Lung Cancer
Mingming Lv et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Epigenetic Manipulation Restores Functions of Defective CD8+ T Cells From Chronic Viral Infection
Fuqin Zhang et al.
MOLECULAR THERAPY (2014)
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
Huili Li et al.
ONCOTARGET (2014)
MicroRNA-17∼92 regulates effector and memory CD8 T-cell fates by modulating proliferation in response to infections
Arif A. Khan et al.
BLOOD (2013)
Architectural Protein Subclasses Shape 3D Organization of Genomes during Lineage Commitment
Jennifer E. Phillips-Cremins et al.
CELL (2013)
Epigenetic Modifications Induced by Blimp-1 Regulate CD8+ T Cell Memory Progression during Acute Virus Infection
Hyun Mu Shin et al.
IMMUNITY (2013)
MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
Jan C. Dudda et al.
IMMUNITY (2013)
Regulation of miRNA biogenesis and turnover in the immune system
Yelena Bronevetsky et al.
IMMUNOLOGICAL REVIEWS (2013)
mir-17-92: a polycistronic oncomir with pleiotropic functions
Virginie Olive et al.
IMMUNOLOGICAL REVIEWS (2013)
Histone modifications for human epigenome analysis
Hiroshi Kimura
JOURNAL OF HUMAN GENETICS (2013)
Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function
Christopher D. Scharer et al.
JOURNAL OF IMMUNOLOGY (2013)
TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
William A. Pastor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
Li-Xin Wang et al.
PLOS ONE (2013)
CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability
Gerritje J. W. van der Windt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation
Sara Trifari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
Masasuke Ohno et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
miR-146a controls the resolution of T cell responses in mice
Lili Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Novel classes of non-coding RNAs and cancer
Jiri Sana et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Topological domains in mammalian genomes identified by analysis of chromatin interactions
Jesse R. Dixon et al.
NATURE (2012)
Spatial partitioning of the regulatory landscape of the X-inactivation centre
Elphege P. Nora et al.
NATURE (2012)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
Perceiving the epigenetic landscape through histone readers
Catherine A. Musselman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients
Jiyun Yang et al.
PLOS ONE (2012)
Tcra gene recombination is supported by a Tcra enhancer- and CTCF-dependent chromatin hub
Han-Yu Shih et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation
Tuoqi Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rescued Tolerant CD8 T Cells Are Preprogrammed to Reestablish the Tolerant State
Andrea Schietinger et al.
SCIENCE (2012)
Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation
Shan Jiang et al.
BLOOD (2011)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Jessica Godin-Ethier et al.
CLINICAL CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Chromatin higher-order structures and gene regulation
Guohong Li et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells
Ben Youngblood et al.
IMMUNITY (2011)
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Mark P. Boldin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets
Bruno Salaun et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
Elisabetta Fratta et al.
MOLECULAR ONCOLOGY (2011)
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells
Yun Ji et al.
NATURE IMMUNOLOGY (2011)
The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets
Cliff Y. Yang et al.
NATURE IMMUNOLOGY (2011)
CD8 Locus Nuclear Dynamics during Thymocyte Development
Eleni Ktistaki et al.
JOURNAL OF IMMUNOLOGY (2010)
Costimulation-Dependent Expression of MicroRNA-214 Increases the Ability of T Cells To Proliferate by Targeting Pten
Peter T. Jindra et al.
JOURNAL OF IMMUNOLOGY (2010)
Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
John A. Craddock et al.
JOURNAL OF IMMUNOTHERAPY (2010)
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
Kotaro Sasaki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
Dan D. Vo et al.
CANCER RESEARCH (2009)
MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo
Bo Liu et al.
LUNG CANCER (2009)
Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells
Madeleine P. Ball et al.
NATURE BIOTECHNOLOGY (2009)
Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells
Peter G. Hawkins et al.
NUCLEIC ACIDS RESEARCH (2009)
Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs
Susana Gonzalez et al.
CELL CYCLE (2008)
CTCF regulates cell cycle progression of αβ T cells in the thymus
Helen Heath et al.
EMBO JOURNAL (2008)
Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B)
Yasuto Araki et al.
JOURNAL OF IMMUNOLOGY (2008)
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
Satoko Matsumura et al.
JOURNAL OF IMMUNOLOGY (2008)
MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells
Lasse Sinkkonen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases
Roberta Benetti et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers
Alla V. Tsytsykova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
miRNA Profiling of Naive, Effector and Memory CD8 T Cells
Haoquan Wu et al.
PLOS ONE (2007)
Loss of T cell receptor-induced Bmi-1 in the KLRG1+ senescent CD8+ T lymphocyte
Maike Heffner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
miR-181a is an intrinsic modulator of T cell sensitivity and selection
Qi-Jing Li et al.
CELL (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b
S. R. James et al.
ONCOGENE (2006)
Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1,-A2,-A3, and-A12 in human cancer cells
Frank Wischnewski et al.
MOLECULAR CANCER RESEARCH (2006)
Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells
Daniel H. Kim et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Histone dynamics on the interleukin-2 gene in response to T-Cell activation
XX Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway
A Insinga et al.
NATURE MEDICINE (2005)
Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells
S Nakata et al.
ONCOGENE (2004)
Long-range intrachromosomal interactions in the T helper type 2 cytokine locus
CG Spilianakis et al.
NATURE IMMUNOLOGY (2004)
Histone sumoylation is associated with transcriptional repression
Y Shilo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential
N Rufer et al.
BLOOD (2001)
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors
WJ Magner et al.
JOURNAL OF IMMUNOLOGY (2000)
Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ lymphocyte immortalization
M Migliaccio et al.
JOURNAL OF IMMUNOLOGY (2000)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)
分享论文
